Levothyroxine: new prescribing advice for patients who experience symptoms on switching between different levothyroxine products

MHRA advise if patient reports persistent symptoms when switching between different tablet formulations, consider consistently prescribing specific product known to be well tolerated by patient. If symptoms/poor control persists despite this measure, consider use of oral solution

Medicines and Healthcare products Regulatory Agency